Evidence map›Paper›PMID 34706224›Full record

ArticleCell reports2021

RNF168 E3 ligase participates in ubiquitin signaling and recruitment of SLX4 during DNA crosslink repair.

Yoko Katsuki, Masako Abe, Seon Young Park, Wenwen Wu, Hiromasa Yabe, Miharu Yabe, Haico van Attikum, Shinichiro Nakada, Tomohiko Ohta, Michael M Seidman and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Yoko KatsukiLaboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Kyoto, Japan. Electronic address: katsuki.yoko.3u@kyoto-u.ac.jp.
Masako AbeThe Core Facility, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Seon Young ParkDepartment of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.
Wenwen WuDepartment of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Hiromasa YabeDepartment of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.
Miharu YabeDepartment of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.
Haico van AttikumDepartment of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Shinichiro NakadaDepartment of Bioregulation and Cellular Response, Graduate School of Medicine, Osaka University, Osaka, Japan; Institute for Advanced Co-Creation Studies, Osaka University, Osaka, Japan.
Tomohiko OhtaDepartment of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Michael M SeidmanLaboratory of Molecular Biology and Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
Yonghwan KimDepartment of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.
Minoru TakataLaboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Kyoto, Japan. Electronic address: takata.minoru.8s@kyoto-u.ac.jp.
Kyoto University · JPSookmyung Women's University · KRSt. Marianna University School of Medicine · JPTokai University · JPLeiden University Medical Center · NLNational Institutes of Health · USThe University of Osaka · JP

Funding

Repair of localized DNA damageZ01AG000746 · NIA · NATIONAL INSTITUTE ON AGING · PI SEIDMAN, MICHAEL · 2007 to 2008
$607k
Intramural NIH HHS Z01 AG000746
6 · The paper itself

Abstract

SLX4/FANCP is a key Fanconi anemia (FA) protein and a DNA repair scaffold for incision around a DNA interstrand crosslink (ICL) by its partner XPF nuclease. The tandem UBZ4 ubiquitin-binding domains of SLX4 are critical for the recruitment of SLX4 to damage sites, likely by binding to K63-linked polyubiquitin chains. However, the identity of the ubiquitin E3 ligase that mediates SLX4 recruitment remains unknown. Using small interfering RNA (siRNA) screening with a GFP-tagged N-terminal half of SLX4 (termed SLX4-N), we identify the RNF168 E3 ligase as a critical factor for mitomycin C (MMC)-induced SLX4 foci formation. RNF168 and GFP-SLX4-N colocalize in MMC-induced ubiquitin foci. Accumulation of SLX4-N at psoralen-laser ICL tracks or of endogenous SLX4 at Digoxigenin-psoralen/UVA ICL is dependent on RNF168. Finally, we find that RNF168 is epistatic with SLX4 in promoting MMC tolerance. We conclude that RNF168 is a critical component of the signal transduction that recruits SLX4 to ICL damage.

Indexed as

DNA RepairSignal TransductionDigoxigeninFicusinHCT116 CellsHumansMCF-7 CellsMitomycinRecombinasesUbiquitinUbiquitin-Protein LigasesDigoxigeninFicusinMitomycinRecombinasesRNF168 protein, humanSLX4 protein, humanUbiquitinUbiquitin-Protein LigasesFanconi anemiainterstrand crosslink repairRNF168SLX4ubiquitination

Identifiers

PMID34706224
PMCPMC11388903
OpenAlexW3209966997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.